Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 8 of 8 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
DRD2
💬1. DRD2
| 8件: Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism 8件: Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap jun ... | Risperidone
Risperidone
💬1. DRD2
| Risperidone | 5件: 8 8, 156, 179, 187, 206 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
AGTR1
💬2. AGTR1
| 16件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Apelin signaling pathway, Renin-angiotensin system, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, AGE-RAGE signaling pathway in diabetic complications, Cushing syndrome, Coronavirus disease - COVID-19, Pathways in cancer, Diabetic cardiomyopathy 16件: Calcium signaling pathway, cGMP-PKG signaling pathway, Phospholipase D signaling pathway, Neuro ... | Losartan
Losartan
💬2. AGTR1
| Losartan | 17件: 17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬2. AGTR1
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
HTR2A
💬3. HTR2A
| 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels 5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic s ... | Risperidone
Risperidone
💬3. HTR2A
| Risperidone | 5件: 8 8, 156, 179, 187, 206 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
KCNJ11
💬4. KCNJ11
| 3件: Insulin secretion Insulin secretion, GnRH secretion, Type II diabetes mellitus | Minoxidil
Minoxidil
💬4. KCNJ11
| Minoxidil | 1件: 179 179 💬4. KCNJ11
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
SLC6A2
💬5. SLC6A2
| 1件: Synaptic vesicle cycle Synaptic vesicle cycle | Methylphenidate
Methylphenidate
💬5. SLC6A2
| Methylphenidate | 7件: 6 6, 13, 34, 84, 113, 179, 206 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
SLC6A3
💬6. SLC6A3
| 7件: Synaptic vesicle cycle Synaptic vesicle cycle, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Alcoholism 7件: Synaptic vesicle cycle, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - ... | Methylphenidate
Methylphenidate
💬6. SLC6A3
| Methylphenidate | 7件: 6 6, 13, 34, 84, 113, 179, 206 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
SLC6A4
💬7. SLC6A4
| 2件: Synaptic vesicle cycle Synaptic vesicle cycle, Serotonergic synapse | Fluoxetine
Fluoxetine
💬7. SLC6A4
| Fluoxetine | 6件: 13 13, 17, 78, 86, 179, 206 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
ABCC8
💬8. ABCC8
| 3件: ABC transporters ABC transporters, Insulin secretion, Type II diabetes mellitus | Minoxidil
Minoxidil
💬8. ABCC8
| Minoxidil | 1件: 179 179 💬8. ABCC8
|